TSH Biopharm Corporation Statistics
Total Valuation
TPEX:8432 has a market cap or net worth of TWD 2.13 billion. The enterprise value is 1.49 billion.
| Market Cap | 2.13B |
| Enterprise Value | 1.49B |
Important Dates
The next estimated earnings date is Tuesday, February 24, 2026.
| Earnings Date | Feb 24, 2026 |
| Ex-Dividend Date | Jun 16, 2025 |
Share Statistics
TPEX:8432 has 38.40 million shares outstanding. The number of shares has increased by 0.05% in one year.
| Current Share Class | 38.40M |
| Shares Outstanding | 38.40M |
| Shares Change (YoY) | +0.05% |
| Shares Change (QoQ) | -0.02% |
| Owned by Insiders (%) | 1.03% |
| Owned by Institutions (%) | 0.72% |
| Float | 15.12M |
Valuation Ratios
The trailing PE ratio is 17.04.
| PE Ratio | 17.04 |
| Forward PE | n/a |
| PS Ratio | 1.67 |
| PB Ratio | 1.25 |
| P/TBV Ratio | 1.85 |
| P/FCF Ratio | 12.38 |
| P/OCF Ratio | 12.08 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 6.68, with an EV/FCF ratio of 8.67.
| EV / Earnings | 11.93 |
| EV / Sales | 1.17 |
| EV / EBITDA | 6.68 |
| EV / EBIT | 7.32 |
| EV / FCF | 8.67 |
Financial Position
The company has a current ratio of 4.77, with a Debt / Equity ratio of 0.01.
| Current Ratio | 4.77 |
| Quick Ratio | 4.12 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.08 |
| Debt / FCF | 0.11 |
| Interest Coverage | 274.31 |
Financial Efficiency
Return on equity (ROE) is 9.62% and return on invested capital (ROIC) is 7.57%.
| Return on Equity (ROE) | 9.62% |
| Return on Assets (ROA) | 6.49% |
| Return on Invested Capital (ROIC) | 7.57% |
| Return on Capital Employed (ROCE) | 11.92% |
| Revenue Per Employee | 16.71M |
| Profits Per Employee | 1.65M |
| Employee Count | 76 |
| Asset Turnover | 0.65 |
| Inventory Turnover | 3.41 |
Taxes
In the past 12 months, TPEX:8432 has paid 49.89 million in taxes.
| Income Tax | 49.89M |
| Effective Tax Rate | 23.73% |
Stock Price Statistics
The stock price has decreased by -6.26% in the last 52 weeks. The beta is 0.41, so TPEX:8432's price volatility has been lower than the market average.
| Beta (5Y) | 0.41 |
| 52-Week Price Change | -6.26% |
| 50-Day Moving Average | 55.95 |
| 200-Day Moving Average | 51.50 |
| Relative Strength Index (RSI) | 40.17 |
| Average Volume (20 Days) | 48,686 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPEX:8432 had revenue of TWD 1.27 billion and earned 125.02 million in profits. Earnings per share was 3.25.
| Revenue | 1.27B |
| Gross Profit | 646.93M |
| Operating Income | 203.81M |
| Pretax Income | 210.20M |
| Net Income | 125.02M |
| EBITDA | 210.50M |
| EBIT | 203.81M |
| Earnings Per Share (EPS) | 3.25 |
Balance Sheet
The company has 914.52 million in cash and 18.91 million in debt, with a net cash position of 895.61 million or 23.32 per share.
| Cash & Cash Equivalents | 914.52M |
| Total Debt | 18.91M |
| Net Cash | 895.61M |
| Net Cash Per Share | 23.32 |
| Equity (Book Value) | 1.70B |
| Book Value Per Share | 37.55 |
| Working Capital | 1.17B |
Cash Flow
In the last 12 months, operating cash flow was 176.08 million and capital expenditures -4.18 million, giving a free cash flow of 171.90 million.
| Operating Cash Flow | 176.08M |
| Capital Expenditures | -4.18M |
| Free Cash Flow | 171.90M |
| FCF Per Share | 4.48 |
Margins
Gross margin is 50.94%, with operating and profit margins of 16.05% and 9.84%.
| Gross Margin | 50.94% |
| Operating Margin | 16.05% |
| Pretax Margin | 16.55% |
| Profit Margin | 9.84% |
| EBITDA Margin | 16.57% |
| EBIT Margin | 16.05% |
| FCF Margin | 13.53% |
Dividends & Yields
This stock pays an annual dividend of 2.12, which amounts to a dividend yield of 3.81%.
| Dividend Per Share | 2.12 |
| Dividend Yield | 3.81% |
| Dividend Growth (YoY) | 65.63% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 65.11% |
| Buyback Yield | -0.05% |
| Shareholder Yield | 3.76% |
| Earnings Yield | 5.88% |
| FCF Yield | 8.08% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on August 28, 2013. It was a forward split with a ratio of 1.1.
| Last Split Date | Aug 28, 2013 |
| Split Type | Forward |
| Split Ratio | 1.1 |
Scores
TPEX:8432 has an Altman Z-Score of 6 and a Piotroski F-Score of 4.
| Altman Z-Score | 6 |
| Piotroski F-Score | 4 |